Categories: NewsTechnology

Tmall Forced To Immediately Halt Over-the-counter Drugs Sales

The Alibaba company runs various online commerce platforms, including Tmall. However, the group has demanded vendors stop offering medicine on the platform, as part of a new directive. Albeit these products seem to be genuine, online platforms have to help their drug sales immediately.

OTC Medicine Sales On Tmall

When consumers think of online commerce platforms such as the ones operated by Alibaba, the last thing most people would purchase is drugs. Healthcare is a serious business, and consumers should never medicine online, regardless of how legitimate the seller may appear to be.

The China Food and Drug Administration has issued a new directive prohibiting drug sales on third-party platforms effectively immediately. No particular reason was given for this instruction, unfortunately. However, the Chinese government wanted to promote online sales of over-the-counter medicine.

By the look of things, the usage of technology to prevent and address issues related to high drug pricing and growing hospital queues did not go as planned. Public hospitals are the dominant market leader when it comes to over-the-counter medicine sales, and online marketplaces were starting to take their claim over the past few months.

An Alibaba spokeswoman told the media that:

“Tmall cooperating and complying with the government’s new policy to stop online drug sales on third-party platforms. While the policy change might impact the whole medicine e-commerce business including Yao.Tmall.com, industry players are exploring new ways to use internet technology to help improve the traditional drug retail system.”

Related Post

Reforming China’s healthcare market will not be as easy as originally assumed. Authorities have expressed their concern regarding the challenges of regulation online drug sales.  With the over-the-counter market set to double in revenue by 2025, regulatory concerns will need to be addressed sooner rather than later.

Unfortunately, this directive will have a big impact on pharmacy chains active on the Tmall platform. The platform had brought in an additional revenue stream for these businesses, all of whom will now have to look for other ways to offer their drugs in an online fashion. This new directive will send shockwaves through the entire pharmacy industry in China, that much is certain.

Source; Reuters

Images credit 1,2

If you liked this article follow us on Twitter @themerklenews and make sure to subscribe to our newsletter to receive the latest bitcoin and altcoin price analysis and the latest cryptocurrency news.

JP Buntinx

JP Buntinx is a FinTech and Bitcoin enthusiast living in Belgium. His passion for finance and technology made him one of the world's leading freelance Bitcoin writers, and he aims to achieve the same level of respect in the FinTech sector.

Share
Published by
JP Buntinx

Recent Posts

Velocity Ticket Debuts As The AI-Powered Invoicing Tool Every Service Business Needs in 2026

Velocity Ticket is trying to fix a major gap in businesses, and the approach it…

2 days ago

Axelar Confirms $4.67M Exploit on Secret Network Bridge, Core Protocol Remains Unaffected

Axelar is moving fast to contain damage after identifying a security incident that has resulted…

3 days ago

Sui Synthetic Dollar suiUSDe Gets Its Own Website

suiUSDe now has a dedicated landing page. The token, officially the eSui Dollar, comes out…

3 days ago

Ventuals Winds Down HIP-3 DEX, vHYPE Withdrawals Now Live For All Holders

Ventuals has fully wound down its HIP-3 DEX, and vHYPE withdrawals are now open. The…

3 days ago

Avalanche Launches Payments Collective With Franklin Templeton And 25 Others

Avalanche has launched the Avalanche Payments Collective, bringing together 28 organizations spanning nearly every layer…

4 days ago

ASTER Whale Reopens 5x Long Days After Getting Fully Liquidated On The Same Token

A wallet tracked as 0x5f91 just opened a fresh 5x leveraged long on ASTER, putting…

4 days ago